Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics

被引:5
|
作者
Fukunishi, Yoshifumi [1 ,2 ]
Mashimo, Tadaaki [2 ,3 ]
Misoo, Kiyotaka [2 ,3 ]
Wakabayashi, Yoshinori [4 ]
Miyaki, Toshiaki [5 ]
Ohta, Seiji [6 ]
Nakamura, Mayu [6 ]
Ikeda, Kazuyoshi [6 ]
机构
[1] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Koto Ku, 2-3-26 Aomi, Tokyo 1350064, Japan
[2] Technol Res Assoc Next Generat Nat Prod Chem, Koto Ku, 2-3-26 Aomi, Tokyo 1350064, Japan
[3] IMSBIO Co Ltd, Toshima Ku, Owl Tower,4-21-1 Higashi Ikebukuro, Tokyo 1700013, Japan
[4] BY HEX LLP, Suginami Ku, 1-19-14 Shimizu, Tokyo 1670033, Japan
[5] DiscoveResource Inc, Minato Ku, 2-4-15 Minami Aoyama, Tokyo 1070062, Japan
[6] LEVEL FIVE Co Ltd, Minato Ku, 21F,Shiodome Shibarikyu Bldg 1-2-3, Tokyo 1050022, Japan
关键词
Computer-aided drug design; Synthetic accessibility; Cloud computing; GPU computing; Virtual screening; Molecular dynamics simulation; MOLECULAR-DYNAMICS SIMULATIONS; CHEMISTRY; COMPLEXITY; CLOUD; ZINC;
D O I
10.2174/1381612822666160414142547
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Computer-aided drug design is still a state-of-the-art process in medicinal chemistry, and the main topics in this field have been extensively studied and well reviewed. These topics include compound databases, ligand-binding pocket prediction, protein-compound docking, virtual screening, target/off-target prediction, physical property prediction, molecular simulation and pharmacokinetics/pharmacodynamics (PK/PD) prediction. Message and Conclusion: However, there are also a number of secondary or miscellaneous topics that have been less well covered. For example, methods for synthesizing and predicting the synthetic accessibility (SA) of designed compounds are important in practical drug development, and hardware/software resources for performing the computations in computer-aided drug design are crucial. Cloud computing and general purpose graphics processing unit (GPGPU) computing have been used in virtual screening and molecular dynamics simulations. Not surprisingly, there is a growing demand for computer systems which combine these resources. In the present review, we summarize and discuss these various topics of drug design.
引用
收藏
页码:3555 / 3568
页数:14
相关论文
共 50 条
  • [21] COMPUTER-AIDED DRUG DESIGN SYSTEM
    SUZUKI, W
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1984, 42 (08) : 732 - 737
  • [22] Proteomics in Computer-Aided Drug Design
    Wang, Ying
    Chiu, Jen-Fu
    He, Qing-Yu
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2005, 1 (01) : 43 - 52
  • [23] UPDATE ON COMPUTER-AIDED DRUG DESIGN
    JACKSON, RC
    CURRENT OPINION IN BIOTECHNOLOGY, 1995, 6 (06) : 646 - 651
  • [24] Computer-Aided Drug Design in Epigenetics
    Lu, Wenchao
    Zhang, Rukang
    Jiang, Hao
    Zhang, Huimin
    Luo, Cheng
    FRONTIERS IN CHEMISTRY, 2018, 6
  • [25] Trends in high-performance computing requirements for computer-aided drug design
    Vacek, George
    Mullally, Dave
    Christensen, Knute
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2008, 4 (01) : 2 - 12
  • [26] Role of Computer-Aided Drug Design in Drug Development
    Gu, Ruoxu
    Wu, Fengxu
    Huang, Zunnan
    MOLECULES, 2023, 28 (20):
  • [27] COMPUTER-AIDED DRUG DESIGN GETS BOOST
    不详
    CHEMICAL & ENGINEERING NEWS, 2008, 86 (42) : 39 - 39
  • [28] Current developments of computer-aided drug design
    Huang, Hung-Jin
    Yu, Hsin Wei
    Chen, Chien-Yu
    Hsu, Chih-Ho
    Chen, Hsin-Yi
    Lee, Kuei-Jen
    Tsai, Fuu-Jen
    Chen, Calvin Yu-Chian
    JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS, 2010, 41 (06) : 623 - 635
  • [29] Recent Advancement in Computer-Aided Drug Design
    Scotti, Luciana
    Scotti, Marcus Tullius
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (15) : 1635 - 1636
  • [30] STRATEGIES FOR INDIRECT COMPUTER-AIDED DRUG DESIGN
    LOEW, GH
    VILLAR, HO
    ALKORTA, I
    PHARMACEUTICAL RESEARCH, 1993, 10 (04) : 475 - 486